Dutch court finds Merck infringes Halozyme's MDASE patent, grants injunction in eight European countries. IV Keytruda unaffected. Halozyme also has German preliminary injunction and US litigation pending.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.
